Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.

Published

Journal Article

BACKGROUND: Despite widespread heparin use in clinical practice, the associated development of thrombocytopenia is an underrecognized and undertreated complication. METHODS: We analyzed data from consecutive hospitalized patients treated with heparin (unfractionated or low molecular weight) for 4 days or longer to determine the incidence, predictors, prognostic significance, and management of "thrombocytopenia," defined as a platelet count less than 150 x 10(9)/L, reduction in platelet count of 50% or more from the admission level, or both. RESULTS: We enrolled 2420 patients (median age, 65.2 years; 43.8% women) in 48 US hospitals. Thrombocytopenia occurred in 881 patients (36.4%; 95% confidence interval [CI], 34.5%-38.3%). Of those who developed thrombocytopenia, 5.1% died, compared with 1.6% of those without thrombocytopenia (odds ratio [OR], 3.4; 95% CI, 2.1-5.6; P< .001). Thrombocytopenia was also associated with greater risk of myocardial infarction (OR, 2.1; 95% CI, 1.5-2.8; P< .001) and congestive heart failure (OR, 1.3; 95% CI, 1.1-1.6; P= .01). After adjustment for important covariates, thrombocytopenia remained an independent predictor of thrombotic and hemorrhagic events. A relative reduction in platelet count of more than 70% was the strongest independent predictor of death (OR, 13.4; 95% CI, 6.5-27.6; P< .001), followed by a relative reduction in platelet count of 50% to 70%, worse Killip class, occurrence of thromboembolic complications, older age, and longer duration of heparin therapy. CONCLUSIONS: Thrombocytopenia occurs frequently after prolonged heparin therapy and is strongly associated with worse short-term clinical outcome. The relative reduction in platelet count is a powerful independent predictor of all-cause mortality in hospitalized patients.

Full Text

Duke Authors

Cited Authors

  • Oliveira, GBF; Crespo, EM; Becker, RC; Honeycutt, EF; Abrams, CS; Anstrom, KJ; Berger, PB; Davidson-Ray, LD; Eisenstein, EL; Kleiman, NS; Moliterno, DJ; Moll, S; Rice, L; Rodgers, JE; Steinhubl, SR; Tapson, VF; Ohman, EM; Granger, CB; Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators,

Published Date

  • January 14, 2008

Published In

Volume / Issue

  • 168 / 1

Start / End Page

  • 94 - 102

PubMed ID

  • 18195201

Pubmed Central ID

  • 18195201

International Standard Serial Number (ISSN)

  • 0003-9926

Digital Object Identifier (DOI)

  • 10.1001/archinternmed.2007.65

Language

  • eng

Conference Location

  • United States